Biobehavioral intervention for Latino/Hispanic young adults with cancer
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
This study is testing two different types of therapy to see which one helps Latino/Hispanic young adults who have survived cancer feel better and manage stress.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | Male |
| Sponsor | University of California, Irvine Academic / other |
| Locations | 1 site (Irvine, California) |
| Trial ID | NCT06338475 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of Goal-focused Emotion-Regulation Therapy (GET) compared to Instrumental Supportive Listening (ISL) in Latino/Hispanic young adult cancer survivors aged 18-39. Participants will undergo six sessions of either intervention over eight weeks, with assessments of psychological outcomes and stress-sensitive biomarkers at multiple time points. The study aims to address the unique challenges faced by this population, including high levels of distress and difficulties in goal navigation following cancer treatment.
Who should consider this trial
Good fit: Ideal candidates are Hispanic/Latino males aged 18-39 who have been diagnosed with cancer between the ages of 15 and 39 and are experiencing distress.
Not a fit: Patients with a history of severe mental health disorders or cognitive impairments may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve emotional regulation and overall well-being for young Latino/Hispanic cancer survivors.
How similar studies have performed: While this approach is tailored to a specific demographic, similar interventions have shown promise in improving psychological outcomes in cancer survivors.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 39 years at time of consent * Male gender; self-identified * A confirmed diagnosis of cancer (any stage) * Diagnosed with cancer between the ages of 15 and 39 * Hispanic/Latino identification * A score ≤ 1.8 on the Goal Navigation Scale or ≥ 4 on the Distress Thermometer * English or Spanish fluency Exclusion Criteria: * lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder (self-report) * compromised cognitive capacity * self-reported medical condition or medication use known to confound measures of systemic inflammation (e.g., autoimmune disorder, active infection)
Where this trial is running
Irvine, California
- University of California, Irvine — Irvine, California, United States (Recruiting)
Study contacts
- Principal investigator: Michael A Hoyt, PhD — University of California, Irvine
- Study coordinator: Michael A Hoyt, PhD
- Email: mahoyt@uci.edu
- Phone: 949-824-5281
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.